摘要
胰管腺癌是全世界致命性最严重的癌症之一,也是美国癌症相关死亡的第四大原因。不管分子病机的进展和抑制这种疾病的努力,这种癌症在美国仍然是一个主要的健康问题。预计到2030年,胰腺癌将成为美国癌症相关死亡的第二大原因。胰腺癌是一种快速侵袭性、高转移性的肿瘤,对常规治疗没有反应。新的证据证明,有一种独特的细胞群被称为癌症干细胞(CSCs)作为潜在的致癌细胞,目前正在努力开发针对这些细胞的治疗策略。CSCs是一种罕见的静止细胞,具有通过不对称/对称细胞分裂自我更新的能力,并可分化为多种类型的肿瘤细胞。研究表明,CSCs对标准治疗具有很高的耐药性,并与耐药、肿瘤复发和转移有关。为了克服这一问题,我们需要新的预防剂,以这些干细胞为目标。天然化合物或植物化学物质具有针对这些CSCs及其信号通路的能力。因此,本文综述了我们目前对胰腺CSCs及其信号通路的认识,以及针对这些细胞的植物化学物质,包括姜黄素、白藜芦醇、茶多酚EGCG(表没食子儿茶素-3-没食子酸)、苦参碱酸、磺胺酸、染料木素、吲哚-3-甲醇、维生素E-δ-tocotrienol、Plumbagin、槲皮素、雷公藤内酯、甘草烯和昆霉素。这些抑制肿瘤干细胞的天然化合物或植物化学物质可能被证明是预防和治疗胰腺癌的有前途的药物。
关键词: 肿瘤干细胞,信号,DCLK 1,天然化合物,化学预防,胰腺癌。
Current Medicinal Chemistry
Title:Targeting Cancer Stem Cells for Chemoprevention of Pancreatic Cancer
Volume: 25 Issue: 22
关键词: 肿瘤干细胞,信号,DCLK 1,天然化合物,化学预防,胰腺癌。
摘要: Pancreatic ductal adenocarcinoma is one of the deadliest cancers worldwide and the fourth leading cause of cancer-related deaths in United States. Regardless of the advances in molecular pathogenesis and consequential efforts to suppress the disease, this cancer remains a major health problem in United States. By 2030, the projection is that pancreatic cancer will be climb up to be the second leading cause of cancer-related deaths in the United States. Pancreatic cancer is a rapidly invasive and highly metastatic cancer, and does not respond to standard therapies. Emerging evidence supports that the presence of a unique population of cells called cancer stem cells (CSCs) as potential cancer inducing cells and efforts are underway to develop therapeutic strategies targeting these cells. CSCs are rare quiescent cells, and with the capacity to self-renew through asymmetric/symmetric cell division, as well as differentiate into various lineages of cells in the cancer. Studies have been shown that CSCs are highly resistant to standard therapy and also responsible for drug resistance, cancer recurrence and metastasis. To overcome this problem, we need novel preventive agents that target these CSCs. Natural compounds or phytochemicals have ability to target these CSCs and their signaling pathways. Therefore, in the present review article, we summarize our current understanding of pancreatic CSCs and their signaling pathways, and the phytochemicals that target these cells including curcumin, resveratrol, tea polyphenol EGCG (epigallocatechin- 3-gallate), crocetinic acid, sulforaphane, genistein, indole-3-carbinol, vitamin E δ- tocotrienol, Plumbagin, quercetin, triptolide, Licofelene and Quinomycin. These natural compounds or phytochemicals, which inhibit cancer stem cells may prove to be promising agents for the prevention and treatment of pancreatic cancers.
Export Options
About this article
Cite this article as:
Targeting Cancer Stem Cells for Chemoprevention of Pancreatic Cancer, Current Medicinal Chemistry 2018; 25 (22) . https://dx.doi.org/10.2174/0929867324666170127095832
DOI https://dx.doi.org/10.2174/0929867324666170127095832 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Neurotrophin Propeptides: Biological Functions and Molecular Mechanisms
Current Protein & Peptide Science Lipid Nucleoside Conjugates for the Treatment of Cancer
Current Pharmaceutical Design Versatility of Cancer Associated Fibroblasts: Commendable Targets for Anti-tumor Therapy
Current Drug Targets Development of Agents that Modulate Protein-Protein Interactions in Membranes
Current Pharmaceutical Design Therapeutic Potential of Targeting PAK Signaling
Anti-Cancer Agents in Medicinal Chemistry Ischemic Colitis: Current Diagnosis and Treatment
Current Drug Targets Enzymes To Die For: Exploiting Nucleotide Metabolizing Enzymes for Cancer Gene Therapy
Current Gene Therapy Ghrelin and Cardiovascular Diseases
Current Cardiology Reviews The Role of NPY and Ghrelin in Anorexia Nervosa
Current Pharmaceutical Design Regulation of Multidrug Resistance by Pro-Inflammatory Cytokines
Current Cancer Drug Targets Oxidative Stress and Mitochondrial Impairment After Treatment with Anti-HIV Drugs: Clinical Implications
Current Pharmaceutical Design An Up-date of Olive Oil Phenols in Inflammation and Cancer: Molecular Mechanisms and Clinical Implications
Current Medicinal Chemistry Targeting the BRCA1/2 Tumor Suppressors
Current Drug Targets Liver and Pancreatic Disease in Cystic Fibrosis: Clinics and Drug Therapy
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) PEDF & Stem Cells: Niche vs. Nurture
Current Drug Delivery WT1 Peptide Vaccine as a Paradigm for “Cancer Antigen-Derived Peptide”-Based Immunotherapy for Malignancies: Successful Induction of Anti-Cancer Effect by Vaccination with a Single Kind of WT1 Peptide
Anti-Cancer Agents in Medicinal Chemistry Nitric Oxide and Pancreatic Cancer Pathogenesis, Prevention, and Treatment
Current Pharmaceutical Design Epigenetics: New Concepts of Old Phenomena in Vascular Physiology
Current Vascular Pharmacology Alzheimer’s Disease And Type 2 Diabetes: Exploring The Association To Obesity And Tyrosine Hydroxylase
CNS & Neurological Disorders - Drug Targets The Development of Copper Radiopharmaceuticals for Imaging and Therapy
Medicinal Chemistry